Keyphrases
Beta-blockers
100%
Short-term Neonatal Outcome
100%
Term Infants
100%
In Utero Exposure
100%
Medical Conditions
33%
High Dose
33%
Life-threatening
33%
Hypertension
33%
Hospitalization
16%
During Pregnancy
16%
Birth Weight
16%
High Prevalence
16%
High Incidence
16%
Migraine
16%
Cardiomyopathy
16%
Ventricular Arrhythmia
16%
Small-for-gestational Age
16%
Gestational Age
16%
Maternity Hospitals
16%
Retrospective Case-Control Design
16%
Cardiac Manifestations
16%
Rheumatic Heart Disease
16%
Asymptomatic Hypoglycemia
16%
Symptomatic Bradycardia
16%
Treatment Indication
16%
Medicine and Dentistry
Beta Adrenergic Receptor Blocking Agent
100%
Drug Megadose
33%
Low Drug Dose
16%
Childbirth
16%
Prevalence
16%
Hypoglycemia
16%
Migraine
16%
Case-Control Study
16%
Cardiomyopathy
16%
Obstetrics
16%
Small for Gestational Age
16%
Gestational Age
16%
Birth Weight
16%
Arrhythmia
16%
Rheumatic Heart Disease
16%
Treatment Indication
16%
Nursing and Health Professions
Beta Adrenergic Receptor Blocking Agent
100%
Drug Megadose
33%
Prevalence
16%
Gestational Age
16%
Hypoglycemia
16%
Small for Date Infant
16%
Birth Weight
16%
Case-Control Study
16%
Heart Arrhythmia
16%
Low Drug Dose
16%
Migraine
16%
Maternity Ward
16%
Cardiomyopathy
16%
Rheumatic Heart Disease
16%
Treatment Indication
16%
Pharmacology, Toxicology and Pharmaceutical Science
Beta Adrenergic Receptor Blocking Agent
100%
Prevalence
16%
Migraine
16%
Case-Control Study
16%
Cardiomyopathy
16%
Heart Arrhythmia
16%
Small for Date Infant
16%
Hypoglycemia
16%
Rheumatic Heart Disease
16%
Biochemistry, Genetics and Molecular Biology
Beta Blocker
100%
Drug Megadose
33%
Prevalence
16%
Low Drug Dose
16%
Cardiac Dysrhythmia
16%
Case-Control Study
16%
Small for Date Infant
16%
Birth Weight
16%